TY - JOUR
T1 - Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment
AU - Boyd, Lenka N.C.
AU - Andini, Katarina D.
AU - Peters, Godefridus J.
AU - Kazemier, Geert
AU - Giovannetti, Elisa
N1 - Funding Information: The authors would like to thank the Bennink Foundation (The Netherlands), The Cancer Center Amsterdam Foundation (The Netherlands) and Associazione Italiana per la Ricerca sul Cancro (AIRC, Italy, AIRC-IG grant 24444 ). Publisher Copyright: © 2021 The Authors Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021
Y1 - 2021
N2 - Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a notably poor prognosis, in urgent need of improved treatment strategies. The desmoplastic PDAC tumor microenvironment (TME), marked by a high concentration of cancer-associated-fibroblasts (CAFs), is a dynamic part of PDAC pathophysiology which occasions a variety of effects throughout the course of pancreatic tumorigenesis and disease evolution. A better understanding of the desmoplastic TME and CAF biology in particular, should provide new opportunities for improving therapeutics. That CAFs have a tumor-supportive role in oncogenesis is well known, yet research evidence has shown that CAFs also have tumor-repressive functions. In this review, we seek to clarify the intriguing heterogeneity and plasticity of CAFs and their ambivalent role in PDAC tumorigenesis and progression. Additionally, we provide recommendations to advance the implementation of CAF-directed PDAC care. An improved understanding of CAFs’ origins, spatial location, functional diversity, and marker determination, as well as CAF behavior during the course of PDAC progression and metastasis will provide essential knowledge for the future improvement of therapeutic strategies for patients suffering from PDAC.
AB - Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a notably poor prognosis, in urgent need of improved treatment strategies. The desmoplastic PDAC tumor microenvironment (TME), marked by a high concentration of cancer-associated-fibroblasts (CAFs), is a dynamic part of PDAC pathophysiology which occasions a variety of effects throughout the course of pancreatic tumorigenesis and disease evolution. A better understanding of the desmoplastic TME and CAF biology in particular, should provide new opportunities for improving therapeutics. That CAFs have a tumor-supportive role in oncogenesis is well known, yet research evidence has shown that CAFs also have tumor-repressive functions. In this review, we seek to clarify the intriguing heterogeneity and plasticity of CAFs and their ambivalent role in PDAC tumorigenesis and progression. Additionally, we provide recommendations to advance the implementation of CAF-directed PDAC care. An improved understanding of CAFs’ origins, spatial location, functional diversity, and marker determination, as well as CAF behavior during the course of PDAC progression and metastasis will provide essential knowledge for the future improvement of therapeutic strategies for patients suffering from PDAC.
KW - CAF biomarkers
KW - CAF therapeutics
KW - Cancer-associated fibroblasts
KW - Heterogeneity
KW - Novel therapeutics
KW - Pancreatic ductal adenocarcinoma
KW - Plasticity
KW - Tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85103506734&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.semcancer.2021.03.006
DO - https://doi.org/10.1016/j.semcancer.2021.03.006
M3 - Article
C2 - 33737108
SN - 1044-579X
JO - Seminars in cancer biology
JF - Seminars in cancer biology
ER -